CIK 0001160308
- Non-accelerated filer
- Smaller reporting company
Savara Inc
Sign in to watch- Ticker
- SVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841318182
- Phone
- +51 285113796
- Business address
- 6836 BEE CAVE ROAD, BUILDING 3, SUITE 201, AUSTIN, TX, 78746
- Former names
- Mast Therapeutics, Inc., ADVENTRX PHARMACEUTICALS INC, BIOKEYS PHARMACEUTICALS INC
- 4 Shares withheld for taxes Chief Medical Officer gave up 49,950 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 381 shares (to pay taxes)
- 4 Grant or award Chief Commercial Officer acquired 85,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Business Officer gave up 381 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 381 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 84,000 shares at $4.71 ($395,900)
- 4 Open-market sale CHIEF FINANCIAL OFFICER sold 10,000 shares at $4.71 ($47,131)
- 4 Open-market sale Director sold 93,843 shares at $4.71 ($442,291)
- 4 Grant or award Chief Medical Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Director acquired 22,500 shares (grant or award)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 30,438 shares (to pay taxes)
- 4 Grant or award Chief Operating Officer acquired 160,000 shares (grant or award)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 109,680 shares (to pay taxes)
- 4 Grant or award Director acquired 22,500 shares (grant or award)
- 4 Grant or award Director acquired 22,500 shares (grant or award)
- 4 Grant or award Director acquired 22,500 shares (grant or award)
- 4 Grant or award Director acquired 22,500 shares (grant or award)
- 4 Grant or award Director acquired 22,500 shares (grant or award)
Page 3 of 22 · 436 filings